Journey Medical Corporation — Form 8-K Summary
Reporting date: November 7, 2023. The filing reports the issuance of a corporate update and financial results for the three months ended September 30, 2023. The detailed results were furnished as Exhibit 99.1, but the provided filing text does not include the press release contents.
Business Context and Period
- Journey Medical Corporation is a Delaware corporation headquartered in Scottsdale, Arizona.
- The company’s common stock trades on the Nasdaq Capital Market under the symbol DERM.
- The filing was made under Form 8-K Item 2.02, Results of Operations and Financial Condition.
Financial Results and Liquidity
The filing text does not provide clear values for revenue, net income or loss, cash flow, margins, debt, cash, liquidity, or other financial metrics. These details may be contained in Exhibit 99.1, which was furnished with the filing but is not included in the provided source text.
Changes Versus Prior Comparable Period
The filing text does not provide a clear comparison with the three months ended September 30, 2022, including changes in revenue, profitability, expenses, cash flow, or balance-sheet items.
Outlook, Commentary, Risks, and Unusual Items
The filing states that the company issued a corporate update, but the provided text does not include management commentary, guidance, outlook, risk disclosures, contingencies, or unusual items from the associated press release.
Investor Verification Items
- Review Exhibit 99.1 for the complete quarterly financial results and corporate update.
- Verify revenue, gross margin, operating expenses, net income or loss, and cash-flow figures for the quarter ended September 30, 2023.
- Compare the reported results with the prior-year comparable quarter and any previously stated expectations.
- Assess cash balances, debt obligations, liquidity runway, and any financing or going-concern disclosures.
- Review any product, regulatory, litigation, contingency, or commercial updates included in the press release.
Filing status: The information and Exhibit 99.1 were furnished and are not deemed filed for purposes of Section 18 of the Securities Exchange Act, nor incorporated by reference into other filings except where expressly stated.